AU2008903050A0 - World's largest implant designed for treatment of cancers & viral disorders - Google Patents

World's largest implant designed for treatment of cancers & viral disorders

Info

Publication number
AU2008903050A0
AU2008903050A0 AU2008903050A AU2008903050A AU2008903050A0 AU 2008903050 A0 AU2008903050 A0 AU 2008903050A0 AU 2008903050 A AU2008903050 A AU 2008903050A AU 2008903050 A AU2008903050 A AU 2008903050A AU 2008903050 A0 AU2008903050 A0 AU 2008903050A0
Authority
AU
Australia
Prior art keywords
cancers
world
treatment
viral disorders
implant designed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2008903050A
Inventor
Alexander George Brian O'neil
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2008903050A0 publication Critical patent/AU2008903050A0/en
Abandoned legal-status Critical Current

Links

AU2008903050A 2008-06-16 World's largest implant designed for treatment of cancers & viral disorders Abandoned AU2008903050A0 (en)

Publications (1)

Publication Number Publication Date
AU2008903050A0 true AU2008903050A0 (en) 2008-07-03

Family

ID=

Similar Documents

Publication Publication Date Title
IL185052A0 (en) Treatment of bone disorders
EP2187743A4 (en) Formulations for treatment of ocular diseases or conditions
EP2010151B8 (en) Treatment of triple receptor negative breast cancer
ZA200810756B (en) Enantiomerically pure flavone derivatives for the treatment of poliferative disorders and processes for their preparation
ZA200905962B (en) Combination therapy for treatment of immune disorders
PL1881823T3 (en) Compositions and methods for treatment of eye disorders
PL2044111T3 (en) Targeting complement factor h for treatment of diseases
ZA201100034B (en) Pharmaceutical compositions for treatment of parkinson's disease
HK1201046A1 (en) Methods of treating ophthalmic diseases
EP2312946A4 (en) Pyrimidine derivatives for treatment of alzheimer's disease
ZA200901523B (en) Use of extracts for the treatment of viral disorders
SI2056863T1 (en) Treatment of ocular diseases
IL216967B (en) 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives and use thereof for the treatment of diseases
WO2011071995A9 (en) Compounds and methods of treating ocular disorders
IL207397A0 (en) Difluorobiphenylamide derivtives for the treatment of ocular hypertension
EP2320939A4 (en) Tissue kallikrein for the treatment of parkinson's disease
WO2010085799A9 (en) Compositions and method for the treatment of parkinson's disease
EP2154138A4 (en) Novel compounds for treatment of psychotic disorders, preparation methods and uses thereof
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
EP1901770A4 (en) Methods for treatment of growth disorders
EP2037943A4 (en) Treatment of connective tissue disorders
EP1895849A4 (en) Methods for treatment of beta-amyloid protein-induced ocular disease
AU2008903050A0 (en) World's largest implant designed for treatment of cancers & viral disorders
AU2007903299A0 (en) Treatment of ocular conditions
PL382339A1 (en) The manner of production of intradural implant for treatment of glaucoma